You might be familiar with Pradaxa—a blood-thinning medication that is used to prevent blood clots and strokes in heart arrhythmia patients and manufactured by Boehringer Ingelheim Pharmaceuticals Incorporated (BIPI). What you might not be aware of are the claims that their product marketing was misleading…
In July, the Food and Drug Administration (FDA) issued a voluntary recall of multiple medications containing valsartan that were manufactured by the Chinese pharmaceutical company, Zhejiang Huahai. The recall occurred after two likely carcinogenic chemicals, N-nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA), were detected in the product—a…
Beginning in July, the U.S. Food and Drug Administration (FDA) has issued a series of recalls for multiple medications that contain the drug valsartan after two likely carcinogenic chemicals were found in valsartan batches that had been imported to the United States from China. Often…
In 2014, A young woman in Snellville, Georgia visited her doctor with claims of depression. Her physician prescribed lamotrigine, also marketed under the tradename Lamictal, a mood-stabilizing anticonvulsant best known for controlling seizures with those who suffer from epilepsy. While the medication seemed to initially…
An Invokana lawsuit filed last year in Canada seeks $1 billion in damages against drug maker Janssen Pharmaceuticals. The lawsuit, filed in September 2015 at the Ontario Superior Court of Justice, seeks class-action status, which is expected to be determined within the next six or…
The diabetes drug Invokana was introduced to the U.S. market in March 2013 and quickly became the go-to type 2 diabetes treatment, although the safety of the medication became a point of contention relatively quickly. In May 2015, the Institute for Safe Medication Practices released…